Brinker Capital Investments’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $533K | Buy |
10,789
+3,570
| +49% | +$181K | ﹤0.01% | 1437 |
|
|
2026
Q1 | $385K | Sell |
7,219
-1,154
| -14% | -$67.8K | ﹤0.01% | 1559 |
|
|
2025
Q4 | $520K | Sell |
8,373
-11,209
| -57% | -$692K | ﹤0.01% | 1580 |
|
|
2025
Q3 | $1.18M | Buy |
19,582
+1,128
| +6% | +$69K | 0.01% | 1138 |
|
|
2025
Q2 | $1.16M | Sell |
18,454
-1,638
| -8% | -$98.4K | 0.01% | 1104 |
|
|
2025
Q1 | $1.21M | Buy |
20,092
+608
| +3% | +$37.8K | 0.01% | 979 |
|
|
2024
Q4 | $1.14M | Buy |
19,484
+496
| +3% | +$29.5K | 0.01% | 976 |
|
|
2024
Q3 | $1.12M | Buy |
18,988
+967
| +5% | +$55.2K | 0.01% | 994 |
|
|
2024
Q2 | $1.01M | Buy |
18,021
+793
| +5% | +$44.4K | 0.01% | 985 |
|
|
2024
Q1 | $1.01M | Sell |
17,228
-3,003
| -15% | -$170K | 0.01% | 979 |
|
|
2023
Q4 | $1.1M | Sell |
20,231
-1,470
| -7% | -$71.8K | 0.01% | 902 |
|
|
2023
Q3 | $1.05M | Sell |
21,701
-1,198
| -5% | -$63.7K | 0.01% | 912 |
|
|
2023
Q2 | $1.29M | Buy |
22,899
+2,158
| +10% | +$119K | 0.01% | 837 |
|
|
2023
Q1 | $1.12M | Buy |
+20,741
| New | +$1.1M | 0.01% | 825 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | – | – | 671 |
|
|
2018
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 665 |
|
|
2018
Q2 | $0 | Sell |
6
-222
| -97% | -$7.23K | ﹤0.01% | 625 |
|
|
2018
Q1 | $7K | Hold |
228
| – | – | ﹤0.01% | 464 |
|
|
2017
Q4 | $7K | Sell |
228
-237,000
| -100% | -$6.83M | ﹤0.01% | 455 |
|
|
2017
Q3 | $6.6M | Sell |
237,228
-27,138
| -10% | -$751K | 0.23% | 99 |
|
|
2017
Q2 | $7.34M | Buy |
264,366
+6,366
| +2% | +$169K | 0.28% | 89 |
|
|
2017
Q1 | $6.51M | Buy |
258,000
+27,000
| +12% | +$655K | 0.27% | 90 |
|
|
2016
Q4 | $5.13M | Hold |
231,000
| – | – | 0.22% | 96 |
|
|
2016
Q3 | $5.6M | Hold |
231,000
| – | – | 0.23% | 87 |
|
|
2016
Q2 | $5.22M | Hold |
231,000
| – | – | 0.22% | 86 |
|
|
2016
Q1 | $4.71M | Hold |
231,000
| – | – | 0.2% | 95 |
|
|
2015
Q4 | $4.71M | Sell |
231,000
-21,000
| -8% | -$420K | 0.2% | 98 |
|
|
2015
Q3 | $4.67M | Sell |
252,000
-24,000
| -9% | -$482K | 0.2% | 94 |
|
|
2015
Q2 | $5.51M | Hold |
276,000
| – | – | 0.21% | 92 |
|
|
2015
Q1 | $5.53M | Hold |
276,000
| – | – | 0.21% | 93 |
|
|
2014
Q4 | $5.2M | Sell |
276,000
-108,000
| -28% | -$1.95M | 0.2% | 99 |
|
|
2014
Q3 | $6.36M | Hold |
384,000
| – | – | 0.24% | 83 |
|
|
2014
Q2 | $6.53M | Hold |
384,000
| – | – | 0.24% | 83 |
|
|
2014
Q1 | $6.32M | Hold |
384,000
| – | – | 0.24% | 86 |
|
|
2013
Q4 | $5.94M | Sell |
384,000
-102,000
| -21% | -$1.52M | 0.23% | 96 |
|
|
2013
Q3 | $6.86M | Sell |
486,000
-72,000
| -13% | -$990K | 0.28% | 84 |
|
|
2013
Q2 | $7.3M | Buy |
+558,000
| New | +$7.23M | 0.31% | 75 |
|
Other funds holding IHI
AAS
Brinker Capital Investments's IHI Position: Q2 2026 in Review
Brinker Capital Investments increased its iShares US Medical Devices ETF (IHI) stake by 49% in Q2 2026, buying an estimated $181K and bringing the position to 10,789 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.
Brinker Capital Investments first reported a position in IHI in Q2 2013 and has held it in 36 quarters since. The position peaked at $7.34M in Q2 2017. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Brinker Capital Investments held 10,789 shares of iShares US Medical Devices ETF worth $533K as of Q2 2026.
- Brinker Capital Investments bought 3,570 iShares US Medical Devices ETF shares in Q2 2026, an estimated $181K.
- iShares US Medical Devices ETF made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1437 holding.
- Brinker Capital Investments first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 36 quarters since.
- Brinker Capital Investments's iShares US Medical Devices ETF position peaked at $7.34M in Q2 2017.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.